Home/Pipeline/digitalABST®

digitalABST®

Antimicrobial resistance insight from bacterial sequencing

CommercialActive

Key Facts

Indication
Antimicrobial resistance insight from bacterial sequencing
Phase
Commercial
Status
Active
Company

About Credence Genomics

AI‑driven NGS platform for comprehensive, rapid pathogen detection and antimicrobial‑resistance profiling.

View full company profile

Therapeutic Areas